Metraipolis › archive › dc_fb5f0037e5fb

Cognitive dysfunction associated with cellular immunotherapy for cancer — Europe PMC PMID:42338466

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42338466
DOI
10.1093/noajnl/vdag021
License (as archived)
solo-consultazione
Archived
2026-11-04T05:22:34.650Z
SHA-256 of the archived text
3b856826a1c04fbfe86998bef9789057cf5bbba7708375c6cd9a16457b1c2caf
Stable URL of this page
https://metraipolis.com/documento/dc_fb5f0037e5fb

How to cite

Cognitive dysfunction associated with cellular immunotherapy for cancer — Europe PMC PMID:42338466 — Europe PMC (en), https://europepmc.org/article/MED/42338466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb5f0037e5fb (Metraipolis archive dc_fb5f0037e5fb, sha256 3b856826a1c04fbfe86998bef9789057cf5bbba7708375c6cd9a16457b1c2caf)
BibTeX
@misc{dcfb5f0037e5fb,
  title = {Cognitive dysfunction associated with cellular immunotherapy for cancer — Europe PMC PMID:42338466},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42338466},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb5f0037e5fb; sha256 3b856826a1c04fbfe86998bef9789057cf5bbba7708375c6cd9a16457b1c2caf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338466. Agents can read the archived copy with the MCP tool read_document.